Acute Fulminant Cerebral Edema Caused by Coxsackievirus A6 Infection: A Case Report

Kang An1, Juan Qian1

  • 1Department of Hematology/Oncology Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine Shanghai China.

Clinical Case Reports
|March 2, 2026
PubMed

Insights

Coxsackievirus A6 (CV-A6) is now the leading cause of hand, foot, and mouth disease (HFMD) in China. This report details a fatal pediatric case of severe HFMD caused by CV-A6, resulting in fulminant cerebral edema.

Area of Science:

  • Virology
  • Neurology
  • Pediatrics

Background:

  • Coxsackievirus A6 (CV-A6) is emerging as a predominant pathogen in hand, foot, and mouth disease (HFMD) outbreaks in China.
  • Previous main causative agents, Enterovirus 71 (EV-71) and Coxsackievirus A16 (CV-A16), are being increasingly replaced by CV-A6.

Purpose of the Study:

  • To report a fatal case of severe HFMD caused by CV-A6.
  • To highlight the potential for CV-A6 to cause severe neurological complications, specifically fulminant cerebral edema.

Main Methods:

  • Case report of a 6-year-old boy with severe HFMD.
  • Clinical presentation, neurological examination, brain CT, and nasopharyngeal swab for CV-A6 detection were utilized.
  • Diagnosis was confirmed through clinical, laboratory, and imaging findings.

Main Results:

  • The patient presented with fever, seizures, unresponsiveness, and signs of severe neurological compromise.
  • Brain CT revealed diffuse parenchymal density decrease, indicative of cerebral edema.
  • CV-A6 was detected in the nasopharyngeal swab, confirming the causative agent.
  • The patient developed fulminant cerebral edema, leading to brain death and subsequent death.

Conclusions:

  • CV-A6 infection can lead to severe and fatal neurological complications in children.
  • Fulminant cerebral edema is a critical complication associated with severe CV-A6 HFMD.
  • Increased vigilance for CV-A6 as a cause of severe HFMD and its neurological sequelae is warranted.

Related Concept Videos

Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
444
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.1K
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
946
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
589
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such...
885
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
645